4th annual IO Combinations 360°

4th annual IO Combinations 360° is organized by The Conference Forum (TCF) and will be held from Jun 20 - 21, 2019 at Wyndham Philadelphia Historic District, Philadelphia, Pennsylvania, United States of America.

Who Should Attend?
The program is designed for all size pharma/biotech companies, academia and investors seeking to enable a patient's immense system to eradicate cancer.

Overview:
This program addresses business aspects, clinical advancements and scientific data in IO combination strategies. The rapid advancement in our understanding of human cancer immunity and immunotherapy combinations is nearly impossible for individual scientists to comprehend. Only together, as an engaged and interactive scientific community, can we hope to enable a patient’s immune system to eradicate cancer.

IO Combinations 360° delivers three key benefits:
• Access to KOLs driving the science
• Partnership opportunities with all stakeholders in Immuno-Oncology & Combinations
• Presentations on the latest data affecting the science, clinical and business advancements in Immuno-Oncology Combinations

Description:
IO Combinations 360° provides the most up-to-date research, data and progress on combination developments to help IO stakeholders:

• Be at the forefront of the most relevant research and developments for IO combinations from key leadership who are at the pulse of cancer immunotherapy
• Foster collaboration amongst others working in all aspects of cancer immunotherapy by rounding up all stakeholders under one roof
• Receive the latest pre-clinical, translational and clinical data from academia and industry
• Better understand what assets are available for potential combinations that may be able to give patients more treatment options
• Create and prioritize combination strategies targeted toward specific tumor types
• Get key investor and analyst evaluations and insights on the IO combination landscape
• Learn about biomarker advancements, neoantigen approaches and more
• Obtain coverage on a wide range of emerging technologies

Key topics for 2019 include:
• Discovery / Preclinical Science
• Bispecifics
• Translational Science and Biomarkers
• Next Generation Cell Therapy
• Clinical Developments
• Operationalizing Combinations
• Business Aspects
• Emerging Technologies

Speakers: Jon Armstrong, Julie Bailis, PhD, Roy Baynes, MD, PhD, Justine Cohen, DO, Asthika Goonewardene, Omid Hamid, MD, Christopher Heery, MD, Darren Hodgson, PhD, Axel Hoos, MD, PhD, Joanna Horobin, MB, ChB, Mahrukh Huseni, Michael Kalos, PhD, Bruce Levine, PhD, Ian McCaffery, PhD, Erin Newburn, PhD, Cokey Nguyen, PhD, Laureen Ojalvo, MD, PhD, Willem Overwijk, PhD, Drew Pardoll, MD, PhD, Mark Paris, PhD, Katy Rezvani, MD, PhD, Carlo Rizzuto, PhD, Will Singleterry, PhD, Danny Wells, PhD

Time: 8:00 am to 4:00 pm